More News

18 October, 2021 By Michelle McAdmin
New Study Suggests COVID-19 Disrupts Insulin Production In The Pancreas and Can Lead to Diabetes

While diabetes doesn’t make someone more or less likely to get sick with COVID-19, it is now well established that diabetes significantly increases the risk of serious complications or death from the virus. But a recent study suggests that COVID may also increase the likelihood of developing diabetes. Published in August 2021 in the journal […]

learn more
11 October, 2021 By Michelle McAdmin
New Study Finds Link Between Air Pollution and Type 2 Diabetes

When we think of risk factors for type 2 diabetes, we think of things going on inside our bodies; our genes, what we eat and drink (or smoke), and how we otherwise take care of ourselves and our bodies. However, a recent study suggests that poor air quality where we live may increase the risk […]

learn more
4 October, 2021 By Michelle McAdmin
More Young People Developing Diabetes, New Study Says

Every day in the United States, someone receives a diagnosis of type 2 diabetes, and according to a new study, an increasing number of those individuals are young. Published in August in the Journal of the American Medical Association, the study found that rates of diabetes in younger Americans rose dramatically between 2001 and 2017. […]

learn more

Call us today to qualify

Monitor and Supplies At Little to No Cost!*

*Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol, when symptoms do not match system readings when you suspect readings may be in accurate, or when you experience symptoms that may be due to high or low blood glucose.

Reference 1: Data on file. Abbott Diabetes Care. 2, FreeStyle Libre 14 day User’s Manual

Indications and Important Safety Information

FreeStyle Libre and FreeStyle Libre 14 day Flash Glucose Monitoring systems are continuous glucose monitoring (CGM) devices indicated for replacing blood glucose testing and detecting trends and tracking patterns aiding in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments in persons (age 18 and older) with diabetes. The systems are intended for single patient use and require a prescription.

CONTRAINDICATIONS: Remove the sensor before MRI, CT scan, X-ray, or diathermy treatment.

WARNINGS/LIMITATIONS: Do not ignore symptoms that may be due to low or high blood glucose, hypoglycemic unawareness, or dehydration. Check sensor glucose readings with a blood glucose meter when Check Blood Glucose symbol appears, when symptoms do not match system readings, or when readings are suspected to be inaccurate. The system does not have alarms unless the sensor is scanned, and the system contains small parts that may be dangerous if swallowed. The system is not approved for pregnant women, persons on dialysis, or critically-ill population. Sensor placement is not approved for sites other than the back of the arm and standard precautions for transmission of blood borne pathogens should be taken. The built-in blood glucose meter is not for use on dehydrated, hypotensive, in shock, hyperglycemic-hyperosmolar state, with or without ketosis, neonates, critically-ill patients, or for diagnosis or screening of diabetes. When using FreeStyle LibreLink app, access to a blood glucose monitoring system is required as the app does not provide one. Review all product information before use or contact Abbott Toll Free (855-632-8658) or visit for detailed indications for use and safety information.html. . FreeStyle, Libre, and related brand marks are trademarks of Abbott Diabetes Care Inc. in various jurisdictions. Other trademarks are the property of their respective owners. ©2018 Abbott. ADC-09691 vLO 10/18